StimAire Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $450K

  • Investors
  • 5

StimAire General Information

Description

Developer of an injectable neuromodulation device designed to create a patient-friendly alternative for healthy sleep. The company's technology also has the potential to treat bladder urgency, gastrointestinal diseases, autoimmune disorders, depression, pain, and cluster headaches, enabling medical practitioners to eliminate major surgery and hospital stays for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Santa Clarita, CA
  • United States
+1 (520)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Santa Clarita, CA
  • United States
+1 (520)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StimAire Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Jun-2024 $450K In Progress Pre-Clinical Trials
3. Early Stage VC (Series A) 01-Nov-2019 Completed Pre-Clinical Trials
2. Early Stage VC 11-Apr-2018 $340K $340K Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2017 Completed Pre-Clinical Trials
To view StimAire’s complete valuation and funding history, request access »

StimAire Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view StimAire’s complete cap table history, request access »

StimAire Patents

StimAire Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021218682-A1 Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications Active 11-Feb-2020
AU-2021218682-B2 Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications Active 11-Feb-2020
CA-3166004-A1 Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications Pending 11-Feb-2020
EP-4103261-A1 Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications Active 11-Feb-2020
EP-4103261-A4 Less invasive and improved peripheral nerve stimulators for obstructive sleep apnea and other applications Active 11-Feb-2020 H02J50/12
To view StimAire’s complete patent history, request access »

StimAire Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StimAire Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Desert Angels Angel Group Minority
Maverick Angels Angel Group Minority
UAVenture Capital Venture Capital Minority
AngelMD Angel Group Minority
University of Arizona University
To view StimAire’s complete investors history, request access »

StimAire FAQs

  • When was StimAire founded?

    StimAire was founded in 2017.

  • Where is StimAire headquartered?

    StimAire is headquartered in Santa Clarita, CA.

  • What is the size of StimAire?

    StimAire has 5 total employees.

  • What industry is StimAire in?

    StimAire’s primary industry is Therapeutic Devices.

  • Is StimAire a private or public company?

    StimAire is a Private company.

  • What is StimAire’s current revenue?

    The current revenue for StimAire is .

  • How much funding has StimAire raised over time?

    StimAire has raised $2.34M.

  • Who are StimAire’s investors?

    Desert Angels, Maverick Angels, UAVenture Capital, AngelMD, and University of Arizona have invested in StimAire.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process